| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 18.457 | 37.221 | 45.274 | 62.883 |
| Total Income - EUR | - | - | - | - | - | - | 18.457 | 37.221 | 47.692 | 74.433 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.103 | 8.522 | 20.649 | 38.543 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 16.353 | 28.699 | 27.043 | 35.890 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 15.919 | 28.364 | 26.613 | 34.021 |
| Employees | - | - | - | - | - | - | 1 | 1 | 2 | 3 |
Check the financial reports for the company - Atimedicis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 25 | 676 | 46.594 | 37.497 |
| Current Assets | - | - | - | - | - | - | 16.989 | 28.987 | 25.465 | 34.907 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 4 | 4 |
| Receivables | - | - | - | - | - | - | 16.116 | 27.372 | 23.932 | 20.629 |
| Cash | - | - | - | - | - | - | 873 | 1.615 | 1.529 | 14.274 |
| Shareholders Funds | - | - | - | - | - | - | 15.960 | 28.412 | 26.661 | 34.069 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.054 | 1.251 | 7.392 | 9.377 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 38.006 | 28.957 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Atimedicis S.r.l.